Related to Amicus Filings in Prometheus v. Mayo Reflect Divide Over Diagnostic Method Patentability

• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• FDA Grants Emergency Use Authorization to Gen-Probe's PCR Test for the H1N1 Flu
  
• Calbiotech Wins Phase I SBIR Contract to Develop Blood-Based Dengue Fever Diagnostic
  
• Chinese Authorities Clear China Medical’s Leukemia Diagnostic Kit
  
• Inostics Gains License from JHU for Development of Cancer-Related Mutation Testing
  
• Enzo to Market GeneNews’ Colorectal Cancer Blood Test in NY and NJ
  
• Minerva Grants Clarient Exclusive Rights to Develop MUC1* Biomarker for Cancer Diagnostics
  
• Akonni Wins $3.2M Grant to Develop Test for Detecting Different Flu Strains
  
• ExonHit Launches Alzheimer Diagnostic for Research Use
  
• Interleukin Genetics Launches Bone Health Genetic Test
  
• Exiqon to Divest Its U.S. CLIA Laboratory Operation
  
• Ferrer InCode to Market BioTheranostics’ Cancer Classification Assay in Four Countries
  
• Celera Grants License Covering KIF6 Testing to UCSF
  
• Life Technologies to Pick Up AcroMetrix for Molecular Diagnostics
  
• Rosetta Genomics to Receive $4.5M in a Registered Direct Offering
  
• Abbott Wins CE Mark for Epithelial Ovarian Cancer Diagnostic
  
• Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab
  
• Biofortuna Chooses Lab901’s ScreenTape System for Multiplex PCR Diagnostic Kits
  
• EraGen and Illumina Enter Cross-Licensing Deal for Molecular Diagnostics